skip to the main content
Contact Us
Go Search
Go Search Menu

Total Anti-Infliximab

Confirms the immunogenicity by detecting total (free and bound) antibody against infliximab

AFIAS Total Anti-Infliximab detects the total (free and bound) antibody against infliximab in the patient’s blood. This helps to physicians for monitor and optimize the appropriate regimen of infliximab.

  • CE AFIAS

Available Instruments

AFIAS-1 AFIAS-6

About Using Reagent

  • Sample Types

    plasma, serum

  • Reaction Time

    22mins (AFIAS)

  • Detection Range

    AFIAS 8-250 AU/mL

  • Indication

    Therapeutic drug monitoring (TDM), Anti-drug antibody (ADA) detection, Immunogenicity

In Your Medical Field

AFIAS Total Anti-Infliximab test detects the total (free and bound) antibody against infliximab with a small amount of human serum or plasma in less than half an hour. This test provides information regarding the patients’ response towards the treatment of drug and based on result physicians can decide the appropriate infliximab regimen.